Get the Stockscreener App
1.3903
3.12%
-0.0497
Tenaya Therapeutics Inc stock is traded at $1.3903, with a volume of 5.12M.
It is down -3.12% in the last 24 hours and down -13.89% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.44
Open:
$1.5
24h Volume:
5.12M
Relative Volume:
1.26
Market Cap:
$228.17M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-1.0533
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
-15.96%
1M Performance:
-13.89%
6M Performance:
+168.27%
1Y Performance:
-28.09%
1-Day Range:
$1.37
$1.54
1-Week Range:
$1.22
$1.65
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.40 | 234.69M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
How resilient is Tenaya Therapeutics Inc. stock in market downturnsQuarterly Growth Report & Long-Term Capital Growth Ideas - newser.com
Is Tenaya Therapeutics Inc. stock positioned well for digital economyPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
Tenaya Therapeutics Inc. stock chart pattern explainedJuly 2025 Trends & AI Based Buy/Sell Signal Reports - newser.com
What analysts say about Tenaya Therapeutics Inc stockCovered Call Writing & Advanced Stock Screening Tools - earlytimes.in
Will Tenaya Therapeutics Inc. stock attract ESG investorsEarnings Beat & Daily Technical Stock Forecast Reports - newser.com
Will Tenaya Therapeutics Inc. stock gain from lower inflationInflation Watch & Low Drawdown Investment Ideas - newser.com
When is the best time to exit Tenaya Therapeutics Inc.Weekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.Weekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
Is Tenaya Therapeutics Inc. stock undervalued vs historical averagesJuly 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
Statistical indicators supporting Tenaya Therapeutics Inc.’s strengthWeekly Profit Summary & Consistent Return Investment Signals - newser.com
How to escape a deep drawdown in Tenaya Therapeutics Inc.2025 Key Lessons & Daily Volume Surge Trade Alerts - newser.com
Can Tenaya Therapeutics Inc. rally from current levelsJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Can Tenaya Therapeutics Inc. stock rebound after recent weaknessWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Will Tenaya Therapeutics Inc. stock continue dividend increasesIndex Update & AI Driven Stock Movement Reports - newser.com
Tenaya Therapeutics (TNYA) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Tenaya Therapeutics Advances Pediatric Cardiomyopathy Research with New Study Update - TipRanks
Can you recover from losses in Tenaya Therapeutics Inc.Entry Point & Safe Entry Momentum Stock Tips - newser.com
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):